| 摘要 |
The invention relates to medicine, in particular, to a medicinal agent for preventing (decelerating) the progression of the apoptotic changes in the cells of various organs and the transformation thereof into necrotic tissue damage. The inventive agent comprises at least one type of 3-oxypyridine or the derivative of 3-oxypyridine, at least one type of purine or the derivative of purine or a nicotine-amide-adenine-dinucleotide. The preferred 3-oxypyridin derivative is embodied in the form of 3-oxy-6-methyl-2-ethyl pyridine succinate. The preferred purine derivative is embodied in the form of inosine. The said medicinal agent can also contain an L-carnitine, alphoscerate choline, and be administered in the form of an injection, a pill, capsule, or suppository. The inventive medicinal agent exhibits a wide therapeutic range and low toxicity, which makes it possible to remove or minimize the causes of apoptotic change activation, to reduce the degree of necrotic tissue damage generated by the pathological process of different etiologies and to decelerate the organism aging process. |
